← Back to Analyst Consensus 
ERNA Buy
Ernexa Therapeutics Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 7, 2026 | Brookline Capital | initiate | — → Buy | — | 38% |
Price Target Trend
May 11, 2026 Latest: $30 Oct 25, 2026
EPS Estimates
+1q $-4.76
Lo: $-4.76 Hi: $-4.76
1 analysts 0q $-3.84
Lo: $-3.84 Hi: $-3.84
1 analysts +1y $-1.86
Lo: $-1.86 Hi: $-1.86
1 analysts 0y $-18.02
Lo: $-18.02 Hi: $-18.02
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days